HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Noël, D. Articles by Jorgensen, C. Search for Related Content PubMed PubMed Citation Articles by Noël, D. Articles by Jorgensen, C.

Short-Term BMP-2 Expression Is Sufficient for In Vivo Osteochondral Differentiation of Mesenchymal Stem Cells

^a Inserm U475, Montpellier, France;
^b Molecular Pathology Laboratory, Hebrew University-Hadassah Faculty of Dental Medicine, Jerusalem, Israel;
^c Institut Gustave Roussy, Villejuif, France;
^d Hôpital Lapeyronie, Service d’Immuno-Rhumatologie, Montpellier, France

Key Words. Chondrocytes • Osteocytes • BMP-2 • Tet-Off system • Vascular endothelial growth factor • Intra-articular • Stromal progenitor cells

Danièle Noël, Ph.D., Inserm U475, 99 Rue Puech Villa, 34197 Montpellier Cedex 5, France. Telephone: 33-04-67-63-62-74; Fax: 33-04-67-04-18-63; e-mail: noel{at}montp.inserm.fr

Currently available murine models to evaluate mesenchymal stem cell (MSC) differentiation are based on cell injection at ectopic sites such as muscle or skin. Due to the importance of environmental factors on the differentiation capacities of stem cells in vivo, we investigated whether the peculiar synovial/cartilaginous environment may influence the lineage specificity of bone morphogenetic protein (BMP)-2-engineered MSCs. To this aim, we used the C3H10T1/2-derived C9 MSCs that express BMP-2 under control of the doxycycline (Dox)-repressible promoter, Tet-Off, and showed in vitro, using the micropellet culture system that C9 MSCs kept their potential to differentiate toward chondrocytes. Implantation of C9 cells, either into the tibialis anterior muscles or into the joints of CB17-severe combined immunodeficient bg mice led to the formation of cartilage and bone filled with bone marrow as soon as day 10. However, no differentiation was observed after injection of naïve MSCs or C9 cells that were repressed to secrete BMP-2 by Dox addition. The BMP-2-induced differentiation of adult MSCs is thus independent of soluble factors present in the local environment of the synovial/cartilaginous tissues. Importantly, we demonstrated that a short-term expression of the BMP-2 growth factor is necessary and sufficient to irreversibly induce bone formation, suggesting that a stable genetic modification of MSCs is not required for stem cell-based bone/cartilage engineering.

This article has been cited by other articles:

				E. J. Koay, G. M. B. Hoben, and K. A. Athanasiou Tissue Engineering with Chondrogenically Differentiated Human Embryonic Stem Cells Stem Cells, September 1, 2007; 25(9): 2183 - 2190. [Abstract] [Full Text] [PDF]

				G. Hou, K. Adriane, and P. K. Feng Bone in Growth in bFGF Versus BMP Combined with bFGF Saturated PLA-PEG-PLA: Experiment in Surgically Created Rabbit Mandibular Defects Journal of Bioactive and Compatible Polymers, September 1, 2005; 20(5): 455 - 474. [Abstract] [PDF]